Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 12,622 shares at $316.88 ($4.0M) on 2024-05-09, disclosed to the SEC on 2024-05-13.
Seasonal sale ($4.0M) by EVP and Chief Clinical Officer — this insider has traded HCA in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $316.88 | 6,311 | $2.0M | 50.0% |
| 2 | $316.88 | 6,311 | $2.0M | 50.0% |
| Total | $316.88 avg | 12,622 | $4.0M | 100% |
| Filing → |
| HCA | SELL | 2024-09-12 | $6.4M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |
| HCA | SELL | 2024-02-02 | $2.0M | — | Filing → |